Related references
Note: Only part of the references are listed.Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Radoslaw Polanski et al.
CLINICAL CANCER RESEARCH (2014)
The Warburg effect then and now: From cancer to inflammatory diseases
Eva M. Palsson-McDermott et al.
BIOESSAYS (2013)
The Neuroplastin Adhesion Molecules Are Accessory Proteins That Chaperone the Monocarboxylate Transporter MCT2 to the Neuronal Cell Surface
Marieangela C. Wilson et al.
PLOS ONE (2013)
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
E. L. Pearce et al.
SCIENCE (2013)
Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1
Clara Pahlman et al.
TRANSPLANT INTERNATIONAL (2013)
Monocarboxylic Acid Transport
Andrew P. Halestrap
COMPREHENSIVE PHYSIOLOGY (2013)
Using the reverse Warburg effect to identify high-risk breast cancer patients Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers
Agnieszka K. Witkiewicz et al.
CELL CYCLE (2012)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: Key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH
Johanna Chiche et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The monocarboxylate transporter familyuStructure and functional characterization
Andrew P. Halestrap
IUBMB LIFE (2012)
The monocarboxylate transporter familyuRole and regulation
Andrew P. Halestrap et al.
IUBMB LIFE (2012)
Role of monocarboxylate transporters in human cancers: state of the art
Celine Pinheiro et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
ACPYPE - AnteChamber PYthon Parser interfacE
Alan W. Sousa da Silva et al.
BMC RESEARCH NOTES (2012)
Hypoxia and energetic tumour metabolism
M. Christiane Brahimi-Horn et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
pH Control Mechanisms of Tumor Survival and Growth
Scott K. Parks et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
Renaud Le Floch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein
Matthew J. Ovens et al.
BIOCHEMICAL JOURNAL (2010)
AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10
Matthew J. Ovens et al.
BIOCHEMICAL JOURNAL (2010)
Studies on the DIDS-binding Site of Monocarboxylate Transporter 1 Suggest a Homology Model of the Open Conformation and a Plausible Translocation Cycle
Marieangela C. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
The SLC16 monocaboxylate transporter family
D. Meredith et al.
XENOBIOTICA (2008)
CD147 immunoglobulin superfamily receptor function and role in pathology
Kathryn T. Iacono et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle
L. H. Bergersen
NEUROSCIENCE (2007)
The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity
Christine Manoharan et al.
MOLECULAR MEMBRANE BIOLOGY (2006)
Automatic atom type and bond type perception in molecular mechanical calculations
Junmei Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism
MS Ullah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Monocarboxylate transporter MCT1 is a target for immunosuppression
CM Murray et al.
NATURE CHEMICAL BIOLOGY (2005)
Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4 - The ancillary protein for the insensitive MCT2 is embigin (gp70)
MC Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
ECH Friesema et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse
NJ Philp et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle
JEM Fox et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells
KS Dimmer et al.
BIOCHEMICAL JOURNAL (2000)
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
P Kirk et al.
EMBO JOURNAL (2000)
Share Paper
